ESC2025 Premium Access

Comparative validation of the AHA PREVENT equation with US and European cardiovascular risk equations among 892,000 adults

Congress Presentation

About the speaker

Doctor James Diao

Harvard Medical School, Boston (United States of America)
0 follower

6 more presentations in this session

Cost-effectiveness of apixaban vs aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial

Speaker: Doctor R. Sandhu (Calgary, CA)

Thumbnail

Global burden of cardiovascular disease and its attributable risk factors and trends in european union countries from 1990 to 2021: a benchmarking analysis for the global burden of disease study 2021

Speaker: Ms A. Parisapogu (Farmington, US)

Thumbnail

Cardiovascular risk factor prevalence, treatment, and control among US adults by income, 2009-2023.

Speaker: Doctor L. Marinacci (Boston, US)

Thumbnail

Should body mass index categories differ by ethnicity? All-cause mortality and incident cardiovascular disease in a multi-ethnic cohort of 400,000 adults

Speaker: Mr C. Li (Auckland, NZ)

Thumbnail

Impact of abnormal findings in health check-ups on medical care: findings from 15 years of health check-ups

Speaker: Doctor S. Kameda (Shimotsuke, JP)

Thumbnail

Access the full session

Public health and health economics

Speakers: Doctor J. Diao, Doctor R. Sandhu, Ms A. Parisapogu, Doctor L. Marinacci, Mr C. Li...
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations